Salmon DNA (Polynucleotides): What It Actually Is and What It Does

If you asked me which treatment generates the most questions in my consultation room purely because of its name, I would not have to think about it. The patient sits down, hesitates for a moment, and asks: “Doctor, is fish DNA really going into my face?”

I understand the hesitation completely. The name does sound strange, and nobody explains it properly before the patient arrives. So let me define the thing first, because everything after that becomes easier to follow.

What we call salmon DNA has nothing to do with the fish as an animal, and even less to do with your own genetics. The name points to a raw material. It is not a promise.

So what is salmon DNA, precisely?

In our professional language the substance is called a polynucleotide. Nucleotides are the bricks that make up a DNA chain. Short chains of these bricks are obtained from the milt of salmon, then purified through several stages, and during that purification the long sequences that would carry genetic information are broken down. What remains in the vial is not the code of a living creature. It is building material, and nothing more.

Why salmon in particular? Because the nucleotide chains of this fish behave in a way that is remarkably close to human tissue, and our immune system does not read them as a foreign threat. Our bodies are quite stingy in this respect — they never spend energy on anything without reason. When a familiar material arrives, the body would rather put it to work than reject it.

Once the material sits in the tissue, we expect two things from it. The first is that these chains form a water-binding mesh, which supports hydration from within rather than from a cream sitting on the surface. The second, and the one I care about more, is that they invite the fibroblasts — the collagen factories in the dermis — to start working again.

Think of a dry sponge next to a fresh one. The dry sponge’s problem is not that it has lost its shape. Its problem is that it has lost its water and the springiness of its internal structure. A polynucleotide aims at both halves of that problem: it gives the sponge some of its water back, and it supports the sponge in rebuilding its own pores.

That distinction matters more than it sounds, because it separates treatments that fill from treatments that repair.

Where does it part ways with filler and mesotherapy?

These three end up in the same sentence so often that patients assume they are interchangeable versions of one idea. They are not. Each answers a different question.

Filler is a question of form. It places support under a region that has dropped, restores volume, and changes proportion. When the underlying scaffolding of the face has genuinely lost support, nothing else does that job.

Classic mesotherapy is a question of nourishment. It carries a cocktail of vitamins, minerals and amino acids into the skin and supports the tissue in a general way.

A polynucleotide answers a third question altogether: can this tissue still repair itself, and can we help it do so?

That is why I position this treatment in my clinic as a repair procedure rather than a plumping one. I explain it to patients like this. Filler is putting a post under a sagging ceiling. Mesotherapy is giving the builder a decent lunch. A polynucleotide is helping the wall renew its own mortar.

Can all three be used in the same patient? Frequently, yes — but never in the same session and never at random. The order is planned, and the order is where most of the thinking happens.

Why does everyone talk about it for the under-eye area?

The skin under the eye is the thinnest skin on the body. In places it measures well under a millimetre. That thinness makes the region difficult to treat and, at the same time, makes polynucleotides genuinely useful there.

Adding volume under the eye is not always the correct answer. Sometimes the complaint is not a hollow at all. Sometimes the skin itself has become transparent and thin, and what the patient sees as a shadow is the vascular network showing through a curtain that has worn out. Thickening and repairing that curtain is a far more sensible move than propping up what lies beneath it. The same logic applies to the fine lines that appear when the skin loses its ability to recover from movement.

Now let me be honest about the limits, because this is where most patients are misled.

The puffiness we call an under-eye bag is the fat pad beneath the eye pushing forward through a weakened barrier. It always reminds me of a hammock that has stretched over the years. When a hammock sags, you do not treat the rope with moisturiser. A polynucleotide will not, unfortunately, remove that bag — and if anyone tells you it will, do not believe them.

Likewise, if the dark circle is entirely a pigment problem, our target changes completely. An under-eye light approach or a different protocol enters the picture instead. I prefer to talk about what we cannot do before we talk about what we can.

Sessions, and the honest timeline

The usual plan is three to four sessions, spaced two to three weeks apart. Each session takes fifteen to twenty minutes, and we apply a numbing cream beforehand.

Here is the part that requires patience. This is not a treatment where you look in the mirror on your way out and say “done.” What we are waiting for is production by your own cells, and cells do not ask us about our schedule. In most patients a difference in the light and texture of the skin begins to show after the second session, and we assess the real result a few weeks after the whole course is finished.

Small bumps at the injection points settle within a few hours, and occasionally a tiny bruise appears. Patients return to normal social life the same day.

Who is a good candidate — and who is not?

In my experience the best responses come from patients who have no meaningful volume loss but whose skin has become thin, dull and marked by fine lines that no longer smooth out on their own. The eye area, the cheeks, the neck and the back of the hands are the regions we work with most often. We also plan polynucleotides as repair support after energy-device treatments or peels, where the tissue benefits from help while it recovers.

The situations where I say no are equally clear. Pregnancy and breastfeeding, an active skin infection at the treatment site, uncontrolled autoimmune disease, and any known serious allergy to fish products. When a patient has that allergy history I do not push the point — there are alternative protocols, and no single treatment is worth that risk.

One more sentence, the same one I say to every patient. What I do with a needle is a beginning. Sustaining it is your homework. Sun protection, sleep, water and cigarettes — those four decide how long our work holds far more than I do.

Sources & Further Reading

• Turkish Ministry of Health / TİTCK — licensing, safety and advertising regulations for medical devices and products: titck.gov.tr
• PubMed — peer-reviewed literature on polynucleotides and tissue repair: pubmed.ncbi.nlm.nih.gov
• American Academy of Dermatology — skin ageing, the moisture barrier and the role of sun protection: aad.org
• Cleveland Clinic — general patient guidance on dark circles under the eyes and their causes: my.clevelandclinic.org

Salmon DNA is not a promise of plumpness. It is support for repair. And no treatment reaches the right address until we have separated what your skin has lost in volume from what it has lost in quality.

---

Is the problem under your eyes thinning skin or a fat pad? Plan a free consultation on WhatsApp.